Saw Palmetto Trial At Higher Dose Would Be “Logical” – NCCAM’s Miller
This article was originally published in The Tan Sheet
Executive Summary
A dose escalation study is a "very logical next step" for saw palmetto researchers to take, according to Heather Miller, PhD, of NCCAM's Division of Extramural Research & Training
You may also be interested in...
Supplement Dose Escalation Trials Help Foster Success – NCCAM’s Berman
Initial dose escalation trials will improve the success rate of dietary supplement clinical trials, according to director of NCCAM's Office of Clinical & Regulatory Affairs, Jonathan Berman, MD, PhD
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say